Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

GBIM

Globelmmune (CE) (GBIM)

Globelmmune Inc (CE)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:USOTC:GBIM
DataHoraFonteTítuloCódigoCompanhia
23/03/201718:23Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:GBIMGlobelmmune Inc (CE)
15/07/201617:19Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:GBIMGlobelmmune Inc (CE)
15/07/201617:11Edgar (US Regulatory)(25)USOTC:GBIMGlobelmmune Inc (CE)
05/07/201617:44Edgar (US Regulatory)Current Report Filing (8-k)USOTC:GBIMGlobelmmune Inc (CE)
20/06/201612:15Edgar (US Regulatory)Confidential Treatment Order (ct Order)USOTC:GBIMGlobelmmune Inc (CE)
12/05/201607:21Edgar (US Regulatory)Quarterly Report (10-q)USOTC:GBIMGlobelmmune Inc (CE)
28/04/201617:22Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:GBIMGlobelmmune Inc (CE)
18/03/201619:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:GBIMGlobelmmune Inc (CE)
24/02/201614:07Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:GBIMGlobelmmune Inc (CE)
16/02/201619:31Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:GBIMGlobelmmune Inc (CE)
22/05/201517:22Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:GBIMGlobelmmune Inc (CE)
22/05/201517:17Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:GBIMGlobelmmune Inc (CE)
10/04/201517:21Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)USOTC:GBIMGlobelmmune Inc (CE)
17/03/201517:19Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:GBIMGlobelmmune Inc (CE)
05/09/201417:46Edgar (US Regulatory)Amended Quarterly Report (10-q/a)USOTC:GBIMGlobelmmune Inc (CE)
17/07/201414:57Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:GBIMGlobelmmune Inc (CE)
08/07/201418:00GlobeNewswire Inc.GlobeImmune Announces Closing of Initial Public Offering and Full Exercise of Underwriter's Overallotment OptionUSOTC:GBIMGlobelmmune Inc (CE)
02/07/201418:11Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)USOTC:GBIMGlobelmmune Inc (CE)
02/07/201418:06Edgar (US Regulatory)Post-effective Amendment Filed Solely to Add Exhibits to a Registration Statement (pos Ex)USOTC:GBIMGlobelmmune Inc (CE)
02/07/201407:00Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:GBIMGlobelmmune Inc (CE)
01/07/201419:14GlobeNewswire Inc.GlobeImmune Announces Pricing of Initial Public OfferingUSOTC:GBIMGlobelmmune Inc (CE)
01/07/201419:00Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:GBIMGlobelmmune Inc (CE)
11/11/201210:30GlobeNewswireGI-5005 Improves Virologic Clearance of HCV in Combination with PegIFN/Ribavirin in IL28B T/T PatientsUSOTC:GBIMGlobelmmune Inc (CE)
10/11/201210:59GlobeNewswireGI-13020 Tarmogen® for the Treatment of Chronic Hepatitis B Generates Antigen-specific T Cell Responses in Key Preclinical S...USOTC:GBIMGlobelmmune Inc (CE)
19/09/201219:00Dow Jones NewsFive IPO Pricings to Break Market's LullUSOTC:GBIM
 Apresentando as notícias mais relevantes sobre:USOTC:GBIM